Respiratory Infections

Delayed or avoided medical care can increase death, severity of illness, and the chronic health impacts of acute illness.

Upping the phase 3 investigational vaccine trial size to 44,000 participants will also allow for the enrollment of new populations.

University of Maryland professor of medical technology explains the ways speed and accuracy are weighed when testing is deployed to detect COVID-19.

A discussion with an Ohio State investigator on early CMR findings among young athletes.

Investigators resumed phase 3 international assessments after independent committees and regulators deemed it safe to do so.

Robert H. Christenson, PhD, University of Maryland, outlines the incentives for how SARS-CoV-2 testing reagents are acquired by institutions.

Robert H. Christenson, PhD, outlines the ways SARS-CoV-2 transmission is prevented during testing, how testing materials are acquired, and more.

Decision Diagnostics Corp. has submitted 2 applications with the FDA for a COVID-19 testing technology that the firm claims can identify the virus in about 10 seconds.

New research presented at ERS shows how critically ill COVID-19 patients face cardiac and pulmonary burdens weeks after recovery.

A Rapid Response in BMJ argues that to achieve Zero-COVID, we need to broaden our thinking to include the controlled and careful acquisition of population immunity.

In this segment, Dysphagia expert Rinki Varindani Desai shares her perspective on the need for an adaptive health care system response that incorporates equity across health burdens.

How a Chicago-based surgeon managed an unprecedented procedure for young woman at the height of the pandemic.

A new report shows a UK-based participant experienced a serious adverse event, but is anticipated to recover.

A total of 9 firms signed the letter promising to put safety at the top of the priority list in ongoing COVID-19 vaccine development projects.

A follow-up on analysis from earlier in the pandemic reveals that virulence in children remained stable over a 5-month period.

The story of an early-infected US physician who launched a non-profit, participated in trials, and guided her peers after overcoming infection.

The phase 1/2 findings show the recently regulated two-dose vaccine was associated with no serious adverse events and antibody response within 21 days.

At a time when schools and college campuses have reopened, an expert discusses adolescents' trends in spreading COVID-19 more easily, and the lack of testing available to them.

Frontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.

A review of the week's top infectious disease news, including links established between mental health and pursuit of need medical care during COVID-19.

How children and adolescents contract, spread, and suffer through the virus differently than other age groups.

New study suggests a connection between widespread mental health challenges and the decline in care during COVID-19.

Rinki Varindani Desai shares some of the challenges COVID-19 patients with lung injury have faced with Medicare after leaving the hospital.

Dysphagia specialist Rinki Varindani Desai shares her perspective on how COVID-19 has impacted her work and patients.

A team at UCSF has created a model which estimates how many pediatric cases are going unnoticed in any US county at any time.

A trio of studies appearing in JAMA today now support steroid use to reduce mortality in patients with severe SARS-CoV-2 infections.

Heat Biologics CEO Jeff Wolf talks with Contagion about the firm's effort to develop a vaccine for the coronavirus which can potentially be administered for some seniors by taking advantage of prior immune mechanisms.

One effort to develop a SARS-CoV-2 vaccine focuses on combining antibody and T cell immunity, using a gp96 protein based technology.

A new CDC Morbidity and Mortality Weekly Report adds information on seroprevalence of SARS-CoV-2 among health care workers in a 13-hospital multistate medical network between April and June of 2020.

A study team examined asthma prevalence in patients hospitalized for COVID-19 with population asthma prevalence and a 4-year average of asthma prevalence in influenza hospitalizations across the United States.